H.C. Wainwright Assumes Viking Therapeutic (VKTX) at Buy, 'An Underappreciated Microcap'
Tweet Send to a Friend
H.C. Wainwright assumes coverage on Viking Therapeutic (NASDAQ: VKTX) with a Buy rating and a price target of $7.00.Analyst Ed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
